Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Galeterone> ?p ?o. }
Showing items 1 to 44 of
44
with 100 items per page.
- Galeterone abstract "Galeterone (TOK-001 or VN/124-1) is an experimental drug being developed by Tokai Pharmaceuticals, Inc. for the treatment of prostate cancer. It is both an androgen receptor antagonist and CYP17A1 inhibitor. It is currently being tested in early phase I/II clinical trials for castration resistant prostate cancer.".
- Galeterone casNumber "851983-85-2".
- Galeterone iupacName "17-(1H-benzimidazol-1-yl)androsta-5,16-dien-3β-ol".
- Galeterone pubchem "11440648".
- Galeterone thumbnail Galeterone.svg?width=300.
- Galeterone wikiPageID "33202985".
- Galeterone wikiPageRevisionID "557342971".
- Galeterone c "26".
- Galeterone casNumber "851983".
- Galeterone chemspiderid "42268103".
- Galeterone h "32".
- Galeterone hasPhotoCollection Galeterone.
- Galeterone inchi "InChI=1S/C26H32N2O/c1-25-13-11-1815-177-8-19-20-9-10-2428-16-27-22-5-3-4-6-2328/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1".
- Galeterone inchikey "PAFKTGFSEFKSQG-PAASFTFBSA-N".
- Galeterone iupacName "17".
- Galeterone kegg "D10125".
- Galeterone molecularWeight "388.25".
- Galeterone n "2".
- Galeterone o "1".
- Galeterone pubchem "11440648".
- Galeterone routesOfAdministration "Oral".
- Galeterone smiles "C[C@]12C=CC[C@]3[C@]1CC[C@@]4[C@@]3CC=C4n5cnc6ccccc56".
- Galeterone subject Category:Experimental_cancer_drugs.
- Galeterone type Agent114778436.
- Galeterone type Antineoplastic102722458.
- Galeterone type CausalAgent100007347.
- Galeterone type CytotoxicDrug103157987.
- Galeterone type Drug103247620.
- Galeterone type ExperimentalCancerDrugs.
- Galeterone type Matter100020827.
- Galeterone type Medicine103740161.
- Galeterone type PhysicalEntity100001930.
- Galeterone type Substance100020090.
- Galeterone type Drug.
- Galeterone type FunctionalSubstance.
- Galeterone comment "Galeterone (TOK-001 or VN/124-1) is an experimental drug being developed by Tokai Pharmaceuticals, Inc. for the treatment of prostate cancer. It is both an androgen receptor antagonist and CYP17A1 inhibitor. It is currently being tested in early phase I/II clinical trials for castration resistant prostate cancer.".
- Galeterone label "Galeterone".
- Galeterone sameAs m.0h684qc.
- Galeterone sameAs Q5518498.
- Galeterone sameAs Q5518498.
- Galeterone sameAs Galeterone.
- Galeterone wasDerivedFrom Galeterone?oldid=557342971.
- Galeterone depiction Galeterone.svg.
- Galeterone isPrimaryTopicOf Galeterone.